Alto Neuroscience, Stock Price on August 30, 2024
| ANRO Stock | 4.31 0.22 5.38% |
If you're considering investing in Alto Stock, it is important to understand the factors that can impact its price. As of today, the current price of Alto Neuroscience, stands at 4.31, as last reported on the 25th of November, with the highest price reaching 4.43 and the lowest price hitting 4.10 during the day. Alto Neuroscience, secures Sharpe Ratio (or Efficiency) of -0.0682, which signifies that the company had a -0.0682% return per unit of risk over the last 3 months. Alto Neuroscience, exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Alto Neuroscience,'s Standard Deviation of 9.89, risk adjusted performance of (0.03), and Mean Deviation of 4.76 to double-check the risk estimate we provide.
As of the 25th of November 2024, Other Stockholder Equity is likely to grow to about 6.5 M, while Total Stockholder Equity is likely to drop (67.7 M). . As of the 25th of November 2024, Price To Sales Ratio is likely to drop to 2,017. In addition to that, Price Earnings Ratio is likely to drop to -16.09. Alto Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Alto |
Sharpe Ratio = -0.0682
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ANRO |
Estimated Market Risk
| 9.99 actual daily | 88 88% of assets are less volatile |
Expected Return
| -0.68 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Alto Neuroscience, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alto Neuroscience, by adding Alto Neuroscience, to a well-diversified portfolio.
Price Book 2.0424 | Book Value 6.671 | Enterprise Value 184.1 M | Shares Float 19.4 M | Shares Outstanding 27 M |
Related Headline
Soleno Therapeutics Headline on 30th of August 2024
Disposition of 30262 shares by Anish Bhatnagar of Soleno The... by news.google.com
Filed transaction by Soleno Therapeutics Director, Officer: Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Alto Neuroscience, Valuation on August 30, 2024
It is possible to determine the worth of Alto Neuroscience, on a given historical date. On August 30, 2024 Alto was worth 12.61 at the beginning of the trading date compared to the closed value of 12.81. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Alto Neuroscience, stock. Still, in general, we apply an absolute valuation method to find Alto Neuroscience,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Alto Neuroscience, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Alto Neuroscience,'s related companies.
| Open | High | Low | Close | Volume | |
| 11.98 | 12.58 | 11.69 | 12.50 | 148,835 | |
08/30/2024 | 12.61 | 13.04 | 12.37 | 12.81 | 183,689 |
| 12.94 | 13.54 | 12.90 | 13.20 | 232,100 |
| Backtest Alto Neuroscience, | | | Alto Neuroscience, History | | | Alto Neuroscience, Valuation | Previous | Next |
Alto Neuroscience, Trading Date Momentum on August 30, 2024
| On September 03 2024 Alto Neuroscience, was traded for 13.20 at the closing time. The top price for the day was 13.54 and the lowest listed price was 12.90 . The trading volume for the day was 232.1 K. The trading history from September 3, 2024 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 3.04% . The overall trading delta against the current closing price is 2.97% . |
Alto Neuroscience, Fundamentals Correlations and Trends
By evaluating Alto Neuroscience,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Alto Neuroscience,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Alto financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Alto Neuroscience, Stock history
Alto Neuroscience, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Alto is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Alto Neuroscience, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Alto Neuroscience, stock prices may prove useful in developing a viable investing in Alto Neuroscience,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 30.9 M | 28.6 M |
Alto Neuroscience, Quarterly Net Working Capital |
|
Alto Neuroscience, Stock Technical Analysis
Alto Neuroscience, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Alto Neuroscience, Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Alto Neuroscience, cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Alto Neuroscience, November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Alto Neuroscience, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Alto Neuroscience, shares will generate the highest return on investment. By undertsting and applying Alto Neuroscience, stock market strength indicators, traders can identify Alto Neuroscience, entry and exit signals to maximize returns
Alto Neuroscience, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Alto Neuroscience,'s price direction in advance. Along with the technical and fundamental analysis of Alto Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Alto to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (1.00) | |||
| Total Risk Alpha | (2.07) | |||
| Treynor Ratio | (0.13) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alto Neuroscience,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Alto Stock, please use our How to Invest in Alto Neuroscience, guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alto Neuroscience,. If investors know Alto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alto Neuroscience, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.85) |
The market value of Alto Neuroscience, is measured differently than its book value, which is the value of Alto that is recorded on the company's balance sheet. Investors also form their own opinion of Alto Neuroscience,'s value that differs from its market value or its book value, called intrinsic value, which is Alto Neuroscience,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alto Neuroscience,'s market value can be influenced by many factors that don't directly affect Alto Neuroscience,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alto Neuroscience,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Alto Neuroscience, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alto Neuroscience,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.